Dexamethasone implant in diabetic macular edema in real-life situations

Eye (Basingstoke)

Volumn 30, Issue 3, 2016, Pages 426-430

  Chhablani, J ^a   Bansal, P ^b   Veritti, D ^c   Sambhana, S ^a   Sarao, V ^c   Pichi, F ^d   Carrai, P ^d   Massaro, D ^d   Lembo, A ^d   Mansour, A M ^e,f   Banker, A ^g   Gupta, S R ^h   Hamam, R ^e,f   Lanzetta, P ^c  

^a L V PRASAD EYE INSTITUTE   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c UNIVERSITY OF UDINE   (Italy)

^d San Giuseppe Hospital   (Italy)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^f RAFIC HARIRI UNIVERSITY HOSPITAL   (Lebanon)

^g Banker's Retina Clinic and Laser Centre   (India)

^h Vasan Eye Care Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE; RANIBIZUMAB; DRUG IMPLANT; GLUCOCORTICOID;

ADULT; ARTICLE; CENTRAL MACULAR THICKNESS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE DURATION; DRUG IMPLANT; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LIFE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NAIVE EYE; NONPROLIFERATIVE DIABETIC RETINOPATHY; REBOUND; RECALCITRANT EYE; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; AGED; CLINICAL TRIAL; DRUG EFFECTS; FLUORESCENCE ANGIOGRAPHY; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MIDDLE AGED; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY;

AGED; DEXAMETHASONE; DIABETIC RETINOPATHY; DRUG IMPLANTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 85014526394     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2015.246     Document Type: Article

References (12)

1. Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010; 117(6): 1064-1077 e1035.
2. Pearson PA, Comstock TL, Ip M, Callanan D, Morse LS, Ashton P et al. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Ophthalmology 2011; 118 (8): 1580-1587.
3. Stewart MW. Critical appraisal of ranibizumab in the treatment of diabetic macular edema. Clin Ophthalmol 2013; 7: 1257-1267.
4. Abcouwer SF. Angiogenic factors and cytokines in diabetic retinopathy. J Clin Cell Immunol 2013; Suppl 1(11). doi:10.4172/2155-9899.
5. Boyer DS, Yoon YH, Belfort Jr R, Bandello F, Maturi RK, Augustin AJ et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 2014; 121(10): 1904-1914.
6. Callanan DG, Gupta S, Boyer DS, Ciulla TA, Singer MA, Kuppermann BD et al. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology 2013; 120(9): 1843-1851.
7. Writing Committee for the Diabetic Retinopathy Clinical Research N, Fong DS, Strauber SF, Aiello LP, Beck RW, Callanan DG et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 2007; 125(4): 469-480.
8. Escobar-Barranco JJ, Pina-Marin B, Fernandez-Bonet M. Dexamethasone implants in patients with naive or refractory diffuse diabetic macular edema. Ophthalmologica 2015; 233 (3-4): 176-185.
9. Jimenez-Gomez B, Gonzalez-Montpetit M, Fonollosa Calduch A, Orive Banuelos A, Valsero Franco S. Effects of ozurdex on intraocular pressure. A real life clinical practice study. Arch Soc Esp Oftalmol 2015; 90(9): 421-425.
10. Thakur A, Kadam R, Kompella UB. Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts. Arch Ophthalmol 2011; 129(7): 914-920.
11. Meyer LM, Schonfeld CL. Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up. J Ocul Pharmacol Ther 2013; 29(6): 560-565.
12. Hayreh SS, Zimmerman MB, Beri M, Podhajsky P. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion. Ophthalmology 2004; 111(1): 133-141.